Pretty much exactly like
the WHI study proved.
In the March 5 edition of the Washington Post, science writer Rob Stein opened his article on
the WHI study with the following sentence.
While
the WHI study linked progestins to increased incidences of cancer, no studies have demonstrated similar risks for progesterone.
Within days, several news organizations reported that the women in
the WHI study were taking estrogens and progesterone (not progestins!).
Check to see if your local paper wrote or carried an article about
the WHI study that confused progesterone with progestins.
It may seem surprising that breast cancer rates declined so quickly after
the WHI study spurred women to drop HRT.
Be sure as well to read our second article in which we describe how the press both managed... and sadly, mis - managed... the latest
WHI study.
The latest
WHI study validates everything that Dr. Lee said about the connection between HRT and cancer.
(13) Immediately after
this WHI study was published in JAMA in 2002, there was a massive switch by women to bio-identical hormones which resulted in a 4 billion dollar loss for Wyeth, the maker of Prempro ™.
WHI study First Arm: The
WHI study (first arm published in JAMA 2002) was terminated early because the combination of premarin ™ and provera ™ (Prempro ™) caused increased breast cancer and heart disease.
WHI Study (Second Arm): All the women in the second arm of the
WHI study had prior hysterectomies (uterus absent), so they did not need the synthetic progestin, called Provera, which is required to prevent the endometrial cancer caused by Premarin alone.
What Was the Women's Health Initiative -
WHI Study The
WHI study was the large NIH sponsored medical study in which synthetic hormones were given to women.
The WHI study consisted of two arms.
(22) Monster Hormones are Chemically Altered Chemically altered hormones were used in
the WHI study, and are routinely handed out by the medical system.
Again, we know from the 2002
WHI study that synthetic hormones cause heart disease, and bioidentical hormones do not.
The massive switch was more a product of the rank and file Physicians who stopped writing prescriptions for Medroxyprogesterone (MPA), also called Provera ™, the synthetic hormone used in
the WHI study.
They DID cause cancer and heart disease in
the WHI study.
(More recently this was upheld by
the WHI study - see www.whi.org or visit our article library to receive a copy of the complete study.
Related sites Press release about the decision to continue WISDOM More information about
the WHI study and the reasons it was stopped JAMA paper describing the results from WISDOM
Related sites Press release about the WISDOM steering committee's recommendation to continue the study The Medical Research Council More information about
the WHI study and the reasons it was stopped JAMA paper describing the results from WISDOM
«It sounds like a very reasonable approach to me,» says Marcia Stefanick of Stanford University, principal investigator in
the WHI study.
In 2004, researchers published results of
the WHI study of estrogen - only therapy, taken for about seven years by women who had had their uteruses surgically removed.
So far,
the WHI studies suggest that they do, with fewer chronic diseases linked to aging like heart problems and diabetes.
Not exact matches
Recently, Manson and colleagues published a long - term
study of the risk of death in women in the two
WHI hormone therapy trials — combined therapy and estrogen alone — from the time of trial enrollment in the mid-1990s until the end of 2014.
Along with the focus on prevention, the
WHI hormone therapy trials were largely
studies of older women — in their 60s and 70s.
The researchers used information from the Women's Health Initiative (
WHI), whose participants were aged 50 to 79 at the start of the
study in 1993.
Then, in 2002, a 16,000 - women
study named the Women's Health Initiative (
WHI) dropped a bombshell: participants were likelier to suffer from heart attacks and breast cancer if they took combination estrogen and progestin hormones.
Ross Prentice, lead investigator of the
WHI breast cancer
study, defends the importance of clinical trials.
Researchers launched the
WHI in part to
study the long - term effects of hormone replacement.
The investigators analyzed data from the Women's Health Initiative (
WHI), an observational
study that follows the health of postmenopausal women ages 50 - 79.
Thisconcern (among others) gave rise to the Women's Health Initiative (
WHI), themost comprehensive «forward - looking»
study of HRT.
Out of more than 150,000 women followed in the
WHI, 9,856 women reported urinary tract stones at the start of or over the course of the
study.
The U.S.
study is part of a big research program called the Women's Health Initiative (
WHI).
In the sleep
study, Carroll and her colleagues drew their data from more than 2,000 women in the
WHI.
Now a new
study evaluating the same
WHI data further concludes that, even with calcium and vitamin D supplements, your risk of fracture is still higher.
The women are part of the larger Women's Health Initiative (
WHI), a national, longitudinal
study investigating the determinants of chronic diseases in postmenopausal women.
The
study involved a randomly selected subgroup of 413 racially and ethnically diverse postmenopausal women, ages 50 to 79, who were participants in the
WHI estrogen - plus - progestin trial, which involved more than 16,500 women nationwide.
The National Heart, Lung and Blood Institute of the U.S. Department of Health and Human Services, the National Cancer Institute and Wyeth - Ayerst Research Laboratories funded the
study, which involved researchers at nine institutions and 15
WHI clinical -
study sites nationwide.
Then the landmark Women's Health Initiative (
WHI)
study found that an HRT treatment of estrogen plus progestin increased the stroke and breast cancer risk in some women.
Aladdin Shadyab, a post doctoral fellow in family medicine and public health at University of California San Diego School of Medicine, and his colleagues
studied women enrolled in the Women's Health Initiative (
WHI), a multi-year
study of post-menopausal women in the U.S. Of the nearly 28,000 women, around half survived to reach age 90.
Dr. Manson was a coauthor on a March 2008
study in the Journal of the American Medical Association that followed up on the
WHI trial.
The
WHI (women's health initiative)
study was halted prematurely because of the negative effects caused by patented hormones during the
study.
Hormone Replacement Therapy Side Effects and HRT Research: The
WHI (Women's Health Initiative) The risks of conventional HRT outweigh the benefits, and major research, including the Women's Health Inititive (
WHI) and the Million Women
Study have finally made that clear.
Still, mainstream medicine ignored the evidence until the Women's Health Initiative (
WHI)
study was halted and results released in the summer of 2002, showed that synthetic HRT definitively increases the risk of breast cancer.
Here's an article by Dr. John Lee about the pivotal Women's Health Initiative (
WHI)
study, which once and for all showed by dangerous synthetic hormones can be.
(7) The 2002
WHI (Women's Health Initiative)
study revealed that synthetic hormones increase the risk of breast cancer.
Therefore, Hormone Replacement Therapy (HRT) medications do not fit into hormone cell receptors like BHRT medications; this mis - fit in molecular structure of HRT appears to have created some of the health problems associated with HRT Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative
Study (
WHI) was released in July 2002 indicating health risks associated with synthetic HRT use).
Finally, in the
WHI Memory
Study, women over age 65 who took hormones were twice as likely to develop dementia as those taking a placebo.»
According to a recently published
study from the Women's Health Initiative (
WHI), women who quit taking combination estrogen - progestin pills face increased cancer risks long after they stop using the drugs.
When the Women's Health Initiative (
WHI) released results from its follow - up
study of women who quit hormone replacement therapy (see our previous article), not everyone got the message straight.